Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine


Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine
DOWNLOAD

Download Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page





Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine


Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine
DOWNLOAD

Author : Vera Hirsh
language : en
Publisher: Frontiers Media SA
Release Date : 2018-01-24

Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine written by Vera Hirsh and has been published by Frontiers Media SA this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-01-24 with categories.


Lung cancer remains a major cause of death in of both women and men in our society. Lung cancer treatment paradigms have changed enormously as we’ve started to understand the genetic complexity and the multiple driver mutations influencing the disease. Therapeutics directed towards, or to inhibit signaling pathways has resulted in increased life spans for our patients. Over the last two decades, we have gone from simple chemotherapy used to treat all, to a personalized medicine approach for the majority. For non-small cell lung cancer patients without driver mutations, the world of immune oncology has arrived. These improved long-term outcomes mean that now our lung cancer patients can live with their cancers, but without progression. The aim of this book is to catalogue the current state of knowledge for the many facets of advanced lung cancer. It describes current treatment approaches for driver mutations, rare mutations, and rare thoracic malignancies such as neuroendocrine tumors. Most importantly, this book addresses the topics of palliative treatment and care which allow our patients to enjoy longer survival with the highest quality of life. We hope you enjoy this e-book. The future is brighter for lung cancer patients and as lung cancer specialists; we finally feel sense optimism about treatment options for our patients.



The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine


The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine
DOWNLOAD

Author : Vera Hirsh
language : en
Publisher: Frontiers Media SA
Release Date : 2015-10-20

The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine written by Vera Hirsh and has been published by Frontiers Media SA this book supported file pdf, txt, epub, kindle and other format this book has been release on 2015-10-20 with Medicine (General) categories.


Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the patients present in advanced stage of the disease and of these only about 2% will be alive at 5 years. NSCLC is the most common form of lung cancer, accounting for approximately 87% of cases. Systemic chemotherapies have been used to treat metastatic NSCLC for decades, but the improvements of outcomes have reached a plateau. Recent advances in understanding signalling pathways for malignant cells, their interconections,the importance of various receptors and biomarkers and the interplay between various oncogenes have led to the development of targeted treatments that are improving both efficacy and safety of the treatments. Knowledge about the advantages of treatments with the targeted agents in metastatic NSCLC is growing rapidly. Combining various targeted agents or sequencing them properly will be important in the era of personalised medicine and overcoming development of the resistence to various targeted agents will be challenging. The importance of a team work,from the diagnosis through various treatments, to supportive care, from the interventional radiologists, pneumologists or surgeons, who have to obtain a satisfactory tumor tissue specimen, to pathologists, radiation and medical oncologists, to supportive care specialists, will be described in our publications. We will cover completely present and future approaches to personalised medicine in this rapidly evolving field of metastatic NSCLC.



Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine


Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine
DOWNLOAD

Author :
language : en
Publisher:
Release Date : 2018

Update On The Treatment Of Metastatic Non Small Cell Lung Cancer Nsclc In New Era Of Personalised Medicine written by and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018 with categories.


Lung Cancer remains a major cause of death in of both women and men in our society. Lung cancer treatment paradigms have changed enormously as we've started to understand the genetic complexity and the multiple driver mutations influencing the disease. Therapeutics directed towards, or to inhibit signaling pathways has resulted in increased life spans for our patients. Over the last two decades, we have gone from simple chemotherapy used to treat all, to a personalized medicine approach for the majority. For non-small cell lung cancer patients without driver mutations, the world of immune oncology has arrived. These improved long-term outcomes mean that now our lung cancer patients can live with their cancers, but without progression. The aim of this book is to catalogue the current state of knowledge for the many facets of advanced lung cancer. It describes current treatment approaches for driver mutations, rare mutations, and rare thoracic malignancies such as neuroendocrine tumors. Most importantly, this book addresses the topics of palliative treatment and care which allow our patients to enjoy longer survival with the highest quality of life. We hope you enjoy this e-book. The future is brighter for lung cancer patients and as lung cancer specialists; we finally feel sense optimism about treatment options for our patients.



Molecular Pathology Of Lung Cancer


Molecular Pathology Of Lung Cancer
DOWNLOAD

Author : Philip T. Cagle
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-06-14

Molecular Pathology Of Lung Cancer written by Philip T. Cagle and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-06-14 with Medical categories.


As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff.



Resistance To Tyrosine Kinase Inhibitors


Resistance To Tyrosine Kinase Inhibitors
DOWNLOAD

Author : Daniele Focosi
language : en
Publisher: Springer
Release Date : 2016-11-14

Resistance To Tyrosine Kinase Inhibitors written by Daniele Focosi and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-11-14 with Medical categories.


The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.



Optimizing Outcomes And Addressing Adversities Of Immunotherapy In Lung Cancer


Optimizing Outcomes And Addressing Adversities Of Immunotherapy In Lung Cancer
DOWNLOAD

Author : Jun Zhang
language : en
Publisher: Frontiers Media SA
Release Date : 2023-10-06

Optimizing Outcomes And Addressing Adversities Of Immunotherapy In Lung Cancer written by Jun Zhang and has been published by Frontiers Media SA this book supported file pdf, txt, epub, kindle and other format this book has been release on 2023-10-06 with Medical categories.




P5 Ehealth An Agenda For The Health Technologies Of The Future


P5 Ehealth An Agenda For The Health Technologies Of The Future
DOWNLOAD

Author : Gabriella Pravettoni
language : en
Publisher: Springer Nature
Release Date : 2019-11-29

P5 Ehealth An Agenda For The Health Technologies Of The Future written by Gabriella Pravettoni and has been published by Springer Nature this book supported file pdf, txt, epub, kindle and other format this book has been release on 2019-11-29 with Psychology categories.


This open access volume focuses on the development of a P5 eHealth, or better, a methodological resource for developing the health technologies of the future, based on patients’ personal characteristics and needs as the fundamental guidelines for design. It provides practical guidelines and evidence based examples on how to design, implement, use and elevate new technologies for healthcare to support the management of incurable, chronic conditions. The volume further discusses the criticalities of eHealth, why it is difficult to employ eHealth from an organizational point of view or why patients do not always accept the technology, and how eHealth interventions can be improved in the future. By dealing with the state-of-the-art in eHealth technologies, this volume is of great interest to researchers in the field of physical and mental healthcare, psychologists, stakeholders and policymakers as well as technology developers working in the healthcare sector.



Women In Molecular And Cellular Oncology 2021


Women In Molecular And Cellular Oncology 2021
DOWNLOAD

Author : Petranel Theresa Ferrao
language : en
Publisher: Frontiers Media SA
Release Date : 2023-10-04

Women In Molecular And Cellular Oncology 2021 written by Petranel Theresa Ferrao and has been published by Frontiers Media SA this book supported file pdf, txt, epub, kindle and other format this book has been release on 2023-10-04 with Medical categories.




Targeted Therapies In Lung Cancer Management Strategies For Nurses And Practitioners


Targeted Therapies In Lung Cancer Management Strategies For Nurses And Practitioners
DOWNLOAD

Author : Marianne Davies
language : en
Publisher: Springer
Release Date : 2019-07-16

Targeted Therapies In Lung Cancer Management Strategies For Nurses And Practitioners written by Marianne Davies and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2019-07-16 with Medical categories.


This book aims to educate nurses and advanced practice providers (APP’s) about known mutations, availability of targeted therapy and the management of patients with non-small cell lung cancer (NSCLC). It will educate nurses and practitioners about the scope of therapy to assure safe and effective lung cancer treatment. In this era of personalized medicine, nurses and APP’s are responsible for guiding patients from diagnosis through treatment. This starts with the identification of patients that can benefit from these therapies, the key role of biopsy acquisition (ie. what to test, when and how often) and treatment selection based on the mutation identified. Readers will learn about the mechanisms of action, administration, potential adverse side effects and unique management strategies for these targeted agents. Lung cancer continues to be the leading cause of cancer death in the United States and worldwide. Recent advances in the identification of specific oncogenic mutations that drive cancer development, growth and metastasis have led to major paradigm shifts in lung cancer treatment. Sophisticated methods are required to identify specific mutations at the time of diagnosis. This book explains how molecularly targeted therapies have been developed that target these drivers. To date, several tyrosine kinase inhibitors have been approved to target the epidermal growth factor receptor (EGFR), EML4-ALK ,ROS1 and BRAF. Most recently, immune checkpoint inhibitors have been approved with some indication that efficacy may be enhanced for patients who overexpress PD-L1. While some driver mutations have been identified, there is ongoing investigation into additional mutations. In the case of driver mutations, lung cancers will develop resistance to therapy. This book provides nurses and APP’s with the mechanisms of resistance that have been identified such as T790 mutation and many others in the EGFR mutation, and shows how the next level of drug development is focused on identifying mechanisms of resistance and development of new agents that overcome these mutations. With this book in hand, nurses and practitioners will be able to navigate patients through this ever expanding field of lung cancer treatment.



Molecular Targeted Therapy Of Lung Cancer


Molecular Targeted Therapy Of Lung Cancer
DOWNLOAD

Author : Yuichi Takiguchi
language : en
Publisher: Springer
Release Date : 2017-01-24

Molecular Targeted Therapy Of Lung Cancer written by Yuichi Takiguchi and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017-01-24 with Medical categories.


This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety. Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.